Innate Pharma S.A. carries a market capitalization of 159.26M, placing it among publicly traded companies globally.
| Market Cap | 159.26M |
| Enterprise Value | N/A |
Innate Pharma S.A.'s stock has gained approximately 10.84967% over the past 52 weeks. The 50-day moving average sits at 1.52, while the 200-day moving average is 1.51.
| Beta (5Y) | N/A |
| 52-Week Price Change | 10.84967% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.51 |
| Average Volume (20 Days) | N/A |